Clinical Trial Update: Safety and Efficacy of Switching to Quetiapine in Outpatients With Schizophrenia

View source ↗

Summary

A completed clinical trial evaluating the safety and efficacy of switching outpatients with schizophrenia to quetiapine.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Schizophrenia

Drugs mentioned

• Quetiapine (quetiapine)

Snippet

Sponsor: AstraZeneca | Conditions: Schizophrenia | Status: COMPLETED